AzTrials
AzTrials

Central Venous CathetersNCT03778437

Facilitating Needle Alignment With Aiming Method

A study testing subclavian vein catheterization, landmark techniques and Ultrasound-guided plus needle guide techniques in people with Central Venous Catheters, run by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Although ultrasound-guided catheterization of the subclavian vein is becoming standard procedure in anesthetic practice, failure to align the needle and the transducer still can lead to possibly complications. In this study, we proposed a new alignment method, namely Aiming Method. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Central Venous Catheters
What is being tested?
subclavian vein catheterization, landmark techniques and Ultrasound-guided plus needle guide techniques
Could I receive a placebo?
No, everyone receives an active treatment
How many people
474 participants
Where
1 siteChina
Study dates
12 Feb 2019to 27 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years to 70 years
  • American Society of Anesthesiologists (ASA) Physical Status Ⅰ-Ⅲ
  • Elective surgery patients requiring subclavian vein catheterization

Who cannot join

  • Local anatomic abnormalities in subclavicular area
  • Preexisting subclavian vein thrombosis or coagulation disorders
  • Refusal of subclavian vein catheterization

Trial locations and contacts

1 site in 1 country.

China1 site
  • Daping Hospital

    Chongqing, 400042

Other trials in China

About this study

Official title: Aiming Method May Facilitate Needle Alignment in Ultrasound-guided Subclavian Vein Catheterization

Although ultrasound-guided catheterization of the subclavian vein is becoming standard procedure in anesthetic practice, failure to align the needle and the transducer still can lead to possibly complications. In this study, we proposed a new alignment method, namely Aiming Method. The purpose of this study is to investigate whether the use of this aiming method improved resident volunteers' performance of ultrasound-guided SC insertion in real patients. Specifically, residents were asked to perform three different methods: landmark techniques, ultrasound-guided with aiming method and ultrasound-guided plus needle guide techniques.

Being tested
subclavian vein catheterization, landmark techniques, Ultrasound-guided plus needle guide techniques

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • subclavian vein catheterizationProcedure or surgery

    Here we introduced a new freehand method, named as Aiming Method, which facilitated the alignment of injection needles with ultrasound beams. During this aiming method, patient is still positioned in Tredelenburg with the arm abducted to 90° and no needle guidance will be used.

  • landmark techniquesProcedure or surgery

    The patient is positioned in Tredelenburg with the arm abducted to 90°. Venipuncture should occur 1 cm lateral to the curvature of the middle third of the clavicle with the needle pointing horizontally directed at the sternal notch. If subclavian vein is missing at the first try, withdraw the needle and direct horizontally at the cricoid cartilage at the second try.

  • Ultrasound-guided plus needle guide techniquesProcedure or surgery

    Subclavian vein catheterization is performed under ultrasound guidance with in-plane technique. The patient is positioned in Tredelenburg with the arm abducted to 90°. During the needle insertion, the needle is secured in the needle guidance device which keeps the alignment of needle and ultrasonic beam.

Study groups in NCT03778437
Study groupRoleWhat they receive
landmark techniquesActive comparatorSubclavian vein catheterization is performed without the guidance of ultrasound. The needle was inserted 1 cm inferior and 1 cm lateral to the junction of the middle and medial thirds of the clavicle (infraclavicular approach)
Receives: Procedure: landmark techniques
ultrasound-guided with aiming methodExperimentalSubclavian vein catheterization is performed with our newly proposed aiming method with the guidance of ultrasound.
Receives: Procedure: subclavian vein catheterization
ultrasound-guided plus needle guide techniquesExperimentalSubclavian vein catheterization is performed under ultrasound guidance with in-plane technique.
Receives: Procedure: Ultrasound-guided plus needle guide techniques

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Procedural time

    the time from skin break to guide wire was positioned into the subclavian vein

    Measured: 24 hours

  2. Number of skin breaks

    number of skin punctures

    Measured: 24 hours

Secondary outcomes (2)
  1. The incidence of arterial puncture

    aspiration of arterial blood during needle insertion or local haematoma in ultrasound image

    Measured: 24 hours

  2. The incidence of pneumothorax

    aspiration of air during needle insertion, or thoracic ultrasonography, or chest radiography

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2018
  2. Study start12 Feb 2019
  3. Primary completion20 Dec 2019
  4. Study completion27 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
474 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03778437
Sponsor's protocol ID
2018(45)
Status last verified
Sep 2020
First submitted
3 Dec 2018
Last updated
23 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing subclavian vein catheterization, landmark techniques and Ultrasound-guided plus needle guide techniques in people with Central Venous Catheters, run by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Procedural time (time frame: 24 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in